Renub

    North America Kidney Transplant Market, Size, Forecast 2023-2027, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Feb 2023
    Pages: 120

    North America Kidney Transplant Market Outlook

    North America Kidney Transplant Market will increase by around US$ 14.76 Billion by 2027. A kidney transplant is a surgical surgery that a healthy kidney is used to replace a damaged or sick kidney donated by another person. The goal of the transplant is to improve or restore the function of the recipient's kidneys, allowing them to live healthier lives with less dependence on dialysis. The success of a kidney transplant is dependent on various factors, including donor-recipient compatibility, good post-operative care, and the recipient's overall health.

    kidney-transplant-market


    In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone. Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients. According to our study, the number of kidney transplants in 2022 will be 30.67 thousand, rising to 39.44 thousand by 2027.


    North America Kidney Transplant Market will grow at a CAGR of 5.38% during the Forecast Period

    Growing demand for kidney transplantation is also one of the key drivers driving expansion potential in the North American sector in the next years. A kidney transplant is reliant on a variety of variables and circumstances. These disorders include renal failure caused by several factors, such as acute dehydration and kidney damage.

    The unexpected spike in COVID-19 cases is also expected to raise demand for PPE kits and gloves in North America. Governments from all across the world have taken several initiatives to combat the spread of the new coronavirus. However, the installation of the lockdown has caused global disruptions in the manufacture, distribution, and delivery of medical supplies. Furthermore, health and clinic centers have declined drastically in recent years in order to preserve social distance. These issues will most likely restrict development opportunities in the kidney transplant industry in the next few years.

    According to the (OPTN) Organ Procurement and Transplantation Network, 42,887 organ transplants will be done in the United States in 2022, a 3.7% increase over 2021. In addition, for the first time, over 25,000 kidney transplants were done in the United States. The number of 25,498 represented a 3.4 percent increase over 2021. Furthermore, factors such as increased public awareness of organ donation, the development of healthcare infrastructure, and the implementation of favorable reimbursement policies will contribute to the market's growth.

    However, problems such as high transplantation costs and lengthy wait times are important impediments to the expansion of the North American kidney transplant industry. Nevertheless, the report shows that the North American kidney transplant market was at US$ 11.36 Billion in 2022.


    By Region: The United States captured the Highest Market Share

    The North American Kidney Transplant Market is divided into; the United States, Mexico, and Canada. In the United States and Canada, there is a large population of individuals with kidney disease, and a significant portion of these individuals require dialysis or a kidney transplant to manage their condition. A kidney transplant can offer these individuals a better quality of life, increased lifespan, and improved health outcomes compared to relying on dialysis alone. Additionally, the availability of advanced medical technology and skilled medical professionals in North American countries make kidney transplantation a safe and effective option for eligible patients.


    By Type: The Living Donor Transplant Market will rise in the Foreseeable Years

    Based on types, the North American market is segmented into; deceased donor transplants and living donor transplants. The living donor transplant segment is forecasted to grow at a significant rate. As the living donor transplant takes place sooner, the kidney has fewer chances of rejection and lasts longer (15-20 years on average).


    By Drugs: The Calcineurin Inhibitors Revenue will grow due to Advancement and Technology in the Healthcare Industry

    The Drugs categorizes into; calcineurin inhibitors, antiproliferative agents, mTOR inhibitors, steroids, and antibodies. Calcineurin inhibitors are a class of immunosuppressive drugs used in the management of organ transplantation, including kidney transplantation, in North American countries. These drugs help prevent the rejection of the transplanted organ by suppressing the immune system's response to the foreign tissue. The two most commonly used calcineurin inhibitors in North America are Cyclosporine and Tacrolimus. Both drugs are highly effective in preventing rejection, but they have different side-effect profiles and dosing requirements. These drugs are administered orally or intravenously and are typically prescribed in combination with other immunosuppressive medications to provide a more complete and effective immunosuppression regimen for transplant patients. Patients on the waiting list vs. Liver organ transplants conducted in 2021 were 90,483 out of 25,498 transplants performed, According to the Organ Procurement and Transplantation Network Data.


    Renub Research report titled “North America Kidney Transplant Market & Number, Forecast by Types (Deceased donor transplant, and living donor transplant), Drugs (Calcineurin inhibitors, Antiproliferative agents, mTor inhibitor, Steroids, and Antibodies), Region (United States, Canada, and Mexico)” studies the North America Kidney Transplant Industry.


    kidney-transplant-market-share


    Type – Kidney Transplant Market breakup from 3 viewpoints:

    1.    Deceased Donor Transplant
    2.    Living Donor Transplant


    Drugs – Kidney Transplant Market breakup from 4 viewpoints

    1.    Calcineurin inhibitors
    2.    Antiproliferative agents
    3.    mTor inhibitor
    4.    Steroids
    5.    Antibodies


    Region – Kidney Transplant Market breakup from 3 Regions:

    1.    United States
    2.    Canada
    3.    Mexico


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered Types, Drugs, and Region
    Region United States, Canada, and Mexico
    Companies Covered Sanofi, Pfizer, Inc., Novartis AG., B. Braun MelsungenAG, Fresenius Medical Care, Medtronic Plc, Trans Medics GroupInc, and Astellas Pharma Inc.
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    North America Kidney Transplant Number and Market

    5.1    Kidney Transplant Number
    5.2    Kidney Transplant Market


    6.    Share Analysis - North America Kidney Transplant Market

    6.1    North America (United States, Mexico & Canada) – Kidney Transplant Number Share
    6.2    North America (United States, Mexico & Canada) – Kidney Transplant Market Share
    6.3    By Types Market Share
    6.4    By Drugs Market Share


    7.    United States - Kidney Transplant Number and Market

    7.1    United States – Kidney Transplant Number
    7.2    United States – Kidney Transplant Market


    8.    Canada - Kidney Transplant Number and Market

    8.1    Canada – Kidney Transplant Number
    8.2    Canada – Kidney Transplant Market


    9.    Mexico- Kidney Transplant Number and Market

    9.1    Mexico – Kidney Transplant Number
    9.2    Mexico – Kidney Transplant Market


    10.    Types - Kidney Transplant Market

    10.1    Deceased Donor Transplant
    10.2    Living Donor Transplant


    11.    Drugs - Kidney Transplant Market

    11.1    Calcineurin Inhibitors
    11.2    Antiproliferative Agents
    11.3    mTOR Inhibitor
    11.4    Steroids
    11.5    Antibodies


    12.    Company Analysis

    12.1    Sanofi

    12.1.1    Overview
    12.1.2    Resent Development
    12.1.3    Revenue

    12.2    Pfizer, Inc.

    12.2.1    Overview
    12.2.2    Resent Development
    12.2.3    Revenue

    12.3    Novartis AG.

    12.3.1    Overview
    12.3.2    Resent Development
    12.3.3    Revenue

    12.4    B.Braun MelsungenAG

    12.4.1    Overview
    12.4.2    Resent Development
    12.4.3    Revenue

    12.5    Fresenius Medical Care

    12.5.1    Overview
    12.5.2    Resent Development
    12.5.3    Revenue

    12.6    Medtronic Plc

    12.6.1    Overview
    12.6.2    Resent Development
    12.6.3    Revenue

    12.7    TransMedics GroupInc

    12.7.1    Overview
    12.7.2    Resent Development
    12.7.3    Revenue

    12.8    Astellas Pharma Inc

    12.8.1    Overview
    12.8.2    Resent Development
    12.8.3    Revenue


    List of Figures:

    Figure-01:    North America – Kidney Transplant Market (Billion US$), 2017 – 2021
    Figure-02:    North America – Forecast for Kidney Transplant Market (Billion US$), 2022 – 2027
    Figure-03:    North America – Kidney Transplant Volume (Number), 2017 – 2021
    Figure-04:    North America – Forecast for Kidney Transplant Volume (Number), 2022 – 2027
    Figure-05:    United States – Kidney Transplant Market (Billion US$), 2017 – 2021
    Figure-06:    United States – Forecast for Kidney Transplant Market (Billion US$), 2022 – 2027
    Figure-07:    United States – Kidney Transplant Volume (Number), 2017 – 2021
    Figure-08:    United States – Forecast for Kidney Transplant Volume (Number), 2022 – 2027
    Figure-09:    Canada – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-10:    Canada – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-11:    Canada – Kidney Transplant Volume (Number), 2017 – 2021
    Figure-12:    Canada – Forecast for Kidney Transplant Volume (Number), 2022 – 2027
    Figure-13:    Mexico – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-14:    Mexico – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-15:    Mexico – Kidney Transplant Volume (Number), 2017 – 2021
    Figure-16:    Mexico – Forecast for Kidney Transplant Volume (Number), 2022 – 2027
    Figure-17:    Deceased Donor Transplant – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-18:    Deceased Donor Transplant – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-19:    Living Donor Transplant – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-20:    Living Donor Transplant – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-21:    Calcineurin Inhibitors – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-22:    Calcineurin Inhibitors – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-23:    Antiproliferative Agents – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-24:    Antiproliferative Agents – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-25:    mTOR Inhibitor – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-26:    mTOR Inhibitor – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-27:    Steroids – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-28:    Steroids – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-29:    Antibodies – Kidney Transplant Market (Million US$), 2017 – 2021
    Figure-30:    Antibodies – Forecast for Kidney Transplant Market (Million US$), 2022 – 2027
    Figure-31:    Sanofi – Global Revenue (Billion US$), 2017 – 2021
    Figure-32:    Sanofi – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-33:    Pfizer, Inc. – Global Revenue (Billion US$), 2017 – 2021
    Figure-34:    Pfizer, Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-35:    Novartis AG. – Global Revenue (Billion US$), 2017 – 2021
    Figure-36:    Novartis AG. – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-37:    B.Braun MelsungenAG – Global Revenue (Billion US$), 2017 – 2021
    Figure-38:    B.Braun MelsungenAG – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-39:    Fresenius Medical Care – Global Revenue (Billion US$), 2017 – 2021
    Figure-40:    Fresenius Medical Care – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-41:    Medtronic Plc – Global Revenue (Billion US$), 2017 – 2021
    Figure-42:    Medtronic Plc – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-43:    Trans Medics GroupInc – Global Revenue (Billion US$), 2017 – 2021
    Figure-44:    Trans Medics GroupInc – Forecast for Global Revenue (Billion US$), 2022 – 2027
    Figure-45:    Astellas Pharma Inc – Global Revenue (Billion US$), 2017 – 2021
    Figure-46:    Astellas Pharma Inc – Forecast for Global Revenue (Billion US$), 2022 – 2027


    List of Tables:

    Table-01:    North America – Kidney Transplant Market Share by Countries (Percent), 2017 – 2021
    Table-02:    North America – Forecast for Kidney Transplant Market Share by Countries (Percent), 2022 – 2027
    Table-03:    North America – Kidney Transplant Volume Share by Countries (Percent), 2017 – 2021
    Table-04:    North America – Forecast for Kidney Transplant Volume Share by Countries (Percent), 2022 – 2027
    Table-05:    North America – Kidney Transplant Market Share by Type (Percent), 2017 – 2021
    Table-06:    North America – Forecast for Kidney Transplant Market Share by Type (Percent), 2022 – 2027
    Table-07:    North America – Kidney Transplant Market Share by Drugs (Percent), 2017 – 2021
    Table-08:    North America – Forecast for Kidney Transplant Market Share by Drugs (Percent), 2022 – 2027

    • Description
      Price
    • Chapter 1, 4 & 5     Pages : 10
      $300
    • Chapter 7     Pages : 4
      $300
    • Chapter 8     Pages : 4
      $300
    • Chapter 9     Pages : 4
      $300
    • Chapter 10     Pages : 4
      $300
    • Chapter 11     Pages : 10
      $600
    • Chapter 12.1     Pages : 5
      $150
    • Chapter 12.2     Pages : 5
      $150
    • Chapter 12.3     Pages : 5
      $150
    • Chapter 12.4     Pages : 5
      $150
    • Chapter 12.5     Pages : 5
      $150
    • Chapter 12.6     Pages : 5
      $150
    • Chapter 12.7     Pages : 5
      $150
    • Chapter 12.8     Pages : 5
      $150

    Related Reports